74 related articles for article (PubMed ID: 11511115)
1. Prothrombotic markers in atrial fibrillation: what is new?
Al-Saady NM; Sopher M
Eur Heart J; 2001 Sep; 22(18):1635-9. PubMed ID: 11511115
[No Abstract] [Full Text] [Related]
2. Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation. Effects of cardioversion and return of left atrial function.
Li-Saw-Hee FL; Blann AD; Gurney D; Lip GY
Eur Heart J; 2001 Sep; 22(18):1741-7. PubMed ID: 11511124
[TBL] [Abstract][Full Text] [Related]
3. A study of blood soluble P-selectin, fibrinogen, and von Willebrand factor levels in idiopathic and lone atrial fibrillation.
Fu R; Wu S; Wu P; Qiu J
Europace; 2011 Jan; 13(1):31-6. PubMed ID: 20852292
[TBL] [Abstract][Full Text] [Related]
4. Relationship of interleukin-6 and C-reactive protein to the prothrombotic state in chronic atrial fibrillation.
Conway DS; Buggins P; Hughes E; Lip GY
J Am Coll Cardiol; 2004 Jun; 43(11):2075-82. PubMed ID: 15172416
[TBL] [Abstract][Full Text] [Related]
5. Thrombogenesis in lone atrial fibrillation: a role for soluble P-selectin?
Montoro-García S; Marín F; Lip GY
Europace; 2011 Jan; 13(1):3-4. PubMed ID: 20974759
[No Abstract] [Full Text] [Related]
6. [Changes of endothelial function indices and their relation to platelet activation in idiopathic atrial fibrillation].
Fu RB; Wu PS; Wu SL; Qiu J
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Apr; 30(4):771-3. PubMed ID: 20423847
[TBL] [Abstract][Full Text] [Related]
7. Immuno-inflammatory predictors of stroke at follow-up in patients with chronic non-valvular atrial fibrillation (NVAF).
Pinto A; Tuttolomondo A; Casuccio A; Di Raimondo D; Di Sciacca R; Arnao V; Licata G
Clin Sci (Lond); 2009 May; 116(10):781-9. PubMed ID: 18980576
[TBL] [Abstract][Full Text] [Related]
8. Effect of acute exercise on the raised plasma fibrinogen, soluble P-selectin and von Willebrand factor levels in chronic atrial fibrillation.
Li-Saw-Hee FL; Blann AD; Edmunds E; Gibbs CR; Lip GY
Clin Cardiol; 2001 May; 24(5):409-14. PubMed ID: 11346250
[TBL] [Abstract][Full Text] [Related]
9. Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation: relationship to plasma von Willebrand factor and soluble E-selectin levels.
Freestone B; Chong AY; Nuttall S; Lip GY
Thromb Res; 2008; 122(1):85-90. PubMed ID: 17996280
[TBL] [Abstract][Full Text] [Related]
10. Correlation of plasma von Willebrand factor levels, an index of endothelial damage/dysfunction, with two point-based stroke risk stratification scores in atrial fibrillation.
Roldán V; Marín F; García-Herola A; Lip GY
Thromb Res; 2005; 116(4):321-5. PubMed ID: 16038717
[TBL] [Abstract][Full Text] [Related]
11. Is an advanced age an additive risk factor to the prothrombotic or hypercoagulable state in atrial fibrillation?
Roldán V; Marín F; García A; Tello-Montoliu A; Lip GY
Int J Cardiol; 2006 Jun; 110(2):265-6. PubMed ID: 16316692
[No Abstract] [Full Text] [Related]
12. Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
Spencer CG; Martin SC; Felmeden DC; Blann AD; Beevers GD; Lip GY
Int J Cardiol; 2004 Apr; 94(2-3):293-300. PubMed ID: 15093996
[TBL] [Abstract][Full Text] [Related]
13. Plasma von Willebrand factor and soluble p-selectin as indices of endothelial damage and platelet activation in 1321 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors.
Conway DS; Pearce LA; Chin BS; Hart RG; Lip GY
Circulation; 2002 Oct; 106(15):1962-7. PubMed ID: 12370220
[TBL] [Abstract][Full Text] [Related]
14. Circulating endothelial cells in atrial fibrillation with and without acute cardiovascular disease.
Freestone B; Lip GY; Chong AY; Nadar S; Lee KW; Blann AD
Thromb Haemost; 2005 Oct; 94(4):702-6. PubMed ID: 16270620
[TBL] [Abstract][Full Text] [Related]
15. Correlation between left atrial size, prothrombotic state and markers of endothelial dysfunction in patients with lone chronic nonrheumatic atrial fibrillation.
Mondillo S; Sabatini L; Agricola E; Ammaturo T; Guerrini F; Barbati R; Pastore M; Fineschi D; Nami R
Int J Cardiol; 2000 Sep; 75(2-3):227-32. PubMed ID: 11077138
[TBL] [Abstract][Full Text] [Related]
16. Haemorheological, platelet and endothelial indices in relation to global measures of cardiovascular risk in hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
Spencer CG; Felmeden DC; Blann AD; Lip GY
J Intern Med; 2007 Jan; 261(1):82-90. PubMed ID: 17222171
[TBL] [Abstract][Full Text] [Related]
17. Alterations of von Willebrand factor and ristocetin cofactor activity during atrial fibrillation.
Kalyoncu U; Dizdar O; Erkan Duman A; Karadag O; Tufan A; Yucel O; Tayfur O; Sen D; Ulger Z; Kepez A; Kocabas U; Haznedaroglu I
Clin Appl Thromb Hemost; 2009 Feb; 15(1):103-8. PubMed ID: 18160605
[TBL] [Abstract][Full Text] [Related]
18. A longitudinal population-based study of prothrombotic factors in elderly subjects with atrial fibrillation: the Rotterdam Study 1990-1999.
Heeringa J; Conway DS; van der Kuip DA; Hofman A; Breteler MM; Lip GY; Witteman JC
J Thromb Haemost; 2006 Sep; 4(9):1944-9. PubMed ID: 16824187
[TBL] [Abstract][Full Text] [Related]
19. Atrial fibrillation and the prothrombotic state in the elderly: the Rotterdam Study.
Conway DS; Heeringa J; Van Der Kuip DA; Chin BS; Hofman A; Witteman JC; Lip GY
Stroke; 2003 Feb; 34(2):413-7. PubMed ID: 12574552
[TBL] [Abstract][Full Text] [Related]
20. Von Willebrand factor for predicting bleeding and mortality real deal or another failed biomarker?
Serebruany VL
J Am Coll Cardiol; 2011 Jun; 57(25):2505-6. PubMed ID: 21497044
[No Abstract] [Full Text] [Related]
[Next] [New Search]
